Galderma Investigational Site 8088

Edmonton, Alberta T5J 3S9

0 studies enrolling now · 1 studies all time

What they study most

Moderate-to-Severe Atopic Dermatitis

Studies at this site

• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed